Timothy J. Harris, Ph.D. - Publications

Affiliations: 
2009 Johns Hopkins University, Baltimore, MD 
Area:
Immunology, Oncology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, et al. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy. PMID 38129211 DOI: 10.1016/j.brachy.2023.10.007  0.325
2014 Walker AJ, Nirscle CJ, Nugent K, Nirschle TR, Harris TJ, Wang H, Sharabi AB, Velerde E, Malek R, Williams R, Cades J, Taparra K, Gajula R, Herman JM, Wong JW, et al. Combining Checkpoint Blockade With Radiation Therapy Results in Tumor and Immunological Responses in an Autochthonous Mouse Model of Lung Cancer : Translational Research International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.302  0.33
2014 Walker A, Nirscle C, Nugent K, Nirschle T, Harris T, Wang H, Sharabi A, Velerde E, Malek R, Williams R, Cades J, Taparra K, Gajula R, Herman J, Wong J, et al. Combining Checkpoint Blockade With Radiation Therapy Results in Tumor and Immunological Responses in an Autochthonous Mouse Model of Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S70. DOI: 10.1016/J.Ijrobp.2014.05.199  0.337
2013 Harris TJ, Drake CG. Primer on tumor immunology and cancer immunotherapy. Journal For Immunotherapy of Cancer. 1: 12. PMID 24829749 DOI: 10.1186/2051-1426-1-12  0.437
2013 Zeng J, Harris TJ, Lim M, Drake CG, Tran PT. Immune modulation and stereotactic radiation: improving local and abscopal responses. Biomed Research International. 2013: 658126. PMID 24324970 DOI: 10.1155/2013/658126  0.324
2013 Wada S, Harris TJ, Tryggestad E, Yoshimura K, Zeng J, Yen HR, Getnet D, Grosso JF, Bruno TC, De Marzo AM, Netto GJ, Pardoll DM, DeWeese TL, Wong J, Drake CG. Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model. International Journal of Radiation Oncology, Biology, Physics. 87: 769-76. PMID 24064321 DOI: 10.1016/J.Ijrobp.2013.07.015  0.532
2013 Wada S, Jackson CM, Yoshimura K, Yen HR, Getnet D, Harris TJ, Goldberg MV, Bruno TC, Grosso JF, Durham N, Netto GJ, Pardoll DM, Drake CG. Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer. Journal of Translational Medicine. 11: 89. PMID 23557194 DOI: 10.1186/1479-5876-11-89  0.739
2013 Zeng J, See AP, Phallen J, Jackson CM, Belcaid Z, Ruzevick J, Durham N, Meyer C, Harris TJ, Albesiano E, Pradilla G, Ford E, Wong J, Hammers HJ, Mathios D, et al. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. International Journal of Radiation Oncology, Biology, Physics. 86: 343-9. PMID 23462419 DOI: 10.1016/J.Ijrobp.2012.12.025  0.559
2013 Boikos SA, Nirschl C, Martin A, Alme A, Harris T, Drake CG. Abstract 1437: Prostate cancer cells up-regulate PD-L1 in response to pro-inflammatory cytokines. Cancer Research. 73: 1437-1437. DOI: 10.1158/1538-7445.Am2013-1437  0.502
2013 Harris T, Wada S, Tryggestad E, Netto G, Wong J, Drake C, DeWeese T. Tumor Vaccination Combined With Radiation Therapy Mitigates Development and Progression of Metastatic Prostate Cancer: Studies in an Autochthonous Murine Prostate Cancer Model International Journal of Radiation Oncology*Biology*Physics. 87: S109. DOI: 10.1016/J.Ijrobp.2013.06.282  0.392
2010 Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, Bruno TC, Durham NM, Hipkiss EL, Pyle KJ, Wada S, Pan F, Pardoll DM, Drake CG. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Molecular Immunology. 47: 1595-600. PMID 20226531 DOI: 10.1016/J.Molimm.2010.02.001  0.785
2009 Yen HR, Harris TJ, Wada S, Grosso JF, Getnet D, Goldberg MV, Liang KL, Bruno TC, Pyle KJ, Chan SL, Anders RA, Trimble CL, Adler AJ, Lin TY, Pardoll DM, et al. Tc17 CD8 T cells: functional plasticity and subset diversity. Journal of Immunology (Baltimore, Md. : 1950). 183: 7161-8. PMID 19917680 DOI: 10.4049/Jimmunol.0900368  0.746
2009 Wada S, Yoshimura K, Hipkiss EL, Harris TJ, Yen HR, Goldberg MV, Grosso JF, Getnet D, Demarzo AM, Netto GJ, Anders R, Pardoll DM, Drake CG. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Research. 69: 4309-18. PMID 19435909 DOI: 10.1158/0008-5472.Can-08-4102  0.786
2009 Getnet D, Maris CH, Hipkiss EL, Grosso JF, Harris TJ, Yen HR, Bruno TC, Wada S, Adler A, Georgantas RW, Jie C, Goldberg MV, Pardoll DM, Drake CG. Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 4675-85. PMID 19342643 DOI: 10.4049/Jimmunol.0803400  0.796
2009 Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, Drake C, Pardoll D, Yu H. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell. 15: 114-23. PMID 19185846 DOI: 10.1016/J.Ccr.2008.12.018  0.538
2008 Harris TJ, Hipkiss EL, Borzillary S, Wada S, Grosso JF, Yen HR, Getnet D, Bruno TC, Goldberg MV, Pardoll DM, DeWeese TL, Drake CG. Radiotherapy augments the immune response to prostate cancer in a time-dependent manner. The Prostate. 68: 1319-29. PMID 18561247 DOI: 10.1002/Pros.20794  0.774
2008 Harris T, Wada S, Yen H, Wong J, Pardoll D, Drake C, DeWeese T. Adjuvant Vaccine Therapy in Combination with Radiation for Treatment of Prostate Cancer: Preclinical Validation in a Mouse Model of Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 72: S63. DOI: 10.1016/J.Ijrobp.2008.06.907  0.366
2007 Grosso JF, Kelleher CC, Harris TJ, Maris CH, Hipkiss EL, De Marzo A, Anders R, Netto G, Getnet D, Bruno TC, Goldberg MV, Pardoll DM, Drake CG. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. The Journal of Clinical Investigation. 117: 3383-92. PMID 17932562 DOI: 10.1172/Jci31184  0.801
2007 Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 179: 4313-7. PMID 17878325 DOI: 10.4049/Jimmunol.179.7.4313  0.771
2007 Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, Grosso JF, Harris TJ, Getnet D, Whartenby KA, Brockstedt DG, Dubensky TW, Chen L, Pardoll DM, Drake CG. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood. 110: 186-92. PMID 17392506 DOI: 10.1182/Blood-2006-12-062422  0.764
2007 Radojcic V, Pletneva MA, Yen H, Harris TJ, Pardoll DM, Drake CG, Luznik L. STAT3 Signaling in Donor-Derived CD4+ T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT. Blood. 110: 2179-2179. DOI: 10.1182/Blood.V110.11.2179.2179  0.768
2006 Palapattu GS, Meeker A, Harris T, Collector MI, Sharkis SJ, DeMarzo AM, Warlick C, Drake CG, Nelson WG. Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium. The Journal of Urology. 176: 813-8. PMID 16813953 DOI: 10.1016/J.Juro.2006.03.077  0.314
2006 Drake CG, Kelleher C, Bruno T, Harris T, Flies D, Getnet D, Hipkiss E, Maris C, Grosso J. Blocking the regulatory T cell molecule LAG-3 augments in vivo anti-tumor immunity in an autochthonous model of prostate cancer Journal of Clinical Oncology. 24: 2573-2573. DOI: 10.1200/Jco.2006.24.18_Suppl.2573  0.606
2005 Aalamian-Mattheis M, Wang J, Jalla S, Hipkiss E, Flies D, Harris T, Drake CG, Pardoll DM, Fuchs EJ. 245: Regression of Prostate Cancer in Animals Treated with Donor Lymphocyte Infusion (DLI) and a Cell Based Tumor Vaccine after Conditioning with a Single Dose of Cyclophosphamide Journal of Urology. 173: 67-67. DOI: 10.1016/S0022-5347(18)34510-5  0.571
Show low-probability matches.